Johnson & Johnson on Monday informed the Delhi High Court that it was ready to pay Rs 25 lakh compensation to patients affected by its faulty articular surface replacement (ASR) hip implants.
However, Johnson & Johnson said the Centre had no jurisdiction under the Drug and Cosmetics Act to enforce the compensation as determined by the expert committee, set up to examine faulty hip implants.
Justice Vibhu Bakhru was hearing Johnson & Johnson's plea challenging the Ministry of Health and Family Welfare's decision asking the company to pay compensation to patients.
The company has also challenged the government decision asking it to pay Rs 65 lakh and Rs 74 lakh compensations to two patients.
The court has asked the government to file its response and listed the hearing for May 2.
--IANS
akk/in/pcj
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app